Higher baseline TSH levels predict early hypothyroidism during cancer immunotherapy

BACKGROUND AND PURPOSE: Immune checkpoint inhibitors (ICIs) are monoclonal antibodies that enhance the immune response against cancer cells. ICIs are generally well tolerated, although endocrine immune-related adverse events (irAEs) are common. We investigated the risk factors for thyroid irAEs in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Luongo, C., Morra, R., Gambale, C., Porcelli, T., Sessa, F., Matano, E., Damiano, V., Klain, M., Schlumberger, M., Salvatore, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357750/
https://www.ncbi.nlm.nih.gov/pubmed/33576954
http://dx.doi.org/10.1007/s40618-021-01508-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357750/
https://www.ncbi.nlm.nih.gov/pubmed/33576954
http://dx.doi.org/10.1007/s40618-021-01508-5

Ejemplares similares